Cargando…
Potent Inhibitory Effect of BJ-3105, a 6-Alkoxypyridin-3-ol Derivative, on Murine Colitis Is Mediated by Activating AMPK and Inhibiting NOX
Inflammatory bowel disease (IBD) is a chronic relapsing inflammation in the gastrointestinal tract. Biological therapeutics and orally available small molecules like tofacitinib (a JAK inhibitor) have been developed to treat IBD, but half of the patients treated with these drugs fail to achieve sust...
Autores principales: | Gurung, Pallavi, Dahal, Sadan, Chaudhary, Prakash, Guragain, Diwakar, Karmacharya, Ujjwala, Kim, Jung-Ae, Jeong, Byeong-Seon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247564/ https://www.ncbi.nlm.nih.gov/pubmed/32365634 http://dx.doi.org/10.3390/ijms21093145 |
Ejemplares similares
-
BJ-3105, a 6-Alkoxypyridin-3-ol Analog, Impairs T Cell Differentiation and Prevents Experimental Autoimmune Encephalomyelitis Disease Progression
por: Timilshina, Maheshwor, et al.
Publicado: (2017) -
Novel Pyridine Bioisostere of Cabozantinib as a Potent c-Met Kinase Inhibitor: Synthesis and Anti-Tumor Activity against Hepatocellular Carcinoma
por: Karmacharya, Ujjwala, et al.
Publicado: (2021) -
BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway
por: Banskota, Suhrid, et al.
Publicado: (2016) -
Copper-Catalyzed Trifluoromethylation of Alkoxypyridine Derivatives
por: Gyorfi, Nandor, et al.
Publicado: (2020) -
6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation
por: Chaudhary, Chhabi Lal, et al.
Publicado: (2022)